{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T11:20:01Z","timestamp":1767093601905},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Programs of Medical Science in Hebei Province","award":["20211165"],"award-info":[{"award-number":["20211165"]}]},{"name":"Key Scientific Research Foundation of Affiliated Hospital of Hebei University","award":["2022ZB03"],"award-info":[{"award-number":["2022ZB03"]}]},{"name":"Medical Science Foundation of Hebei University","award":["2023X04"],"award-info":[{"award-number":["2023X04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-024-02038-5","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T06:01:56Z","timestamp":1727503316000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Biphasic effects of single-dose intravenous injection of uridine adenosine tetraphosphate on blood pressure in mice"],"prefix":"10.1186","volume":"29","author":[{"given":"Yue","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Yang","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"key":"2038_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","volume":"390","author":"GBD Causes of Death Collaborators","year":"2017","unstructured":"GBD Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: A systematic analysis for the global burden of disease study 2016. Lancet. 2017;390:1151\u2013210.","journal-title":"Lancet"},{"key":"2038_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2016.19043","volume":"317","author":"MH Forouzanfar","year":"2017","unstructured":"Forouzanfar MH, Liu P, Roth GA, et al. Global burden of hypertension and systolic lood pressure of at least 110 to 115 mm Hg, 1990\u20132015. JAMA. 2017;317:165.","journal-title":"JAMA"},{"key":"2038_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nm1188","volume":"11","author":"V Jankowski","year":"2005","unstructured":"Jankowski V, T\u00f6lle M, Vanholder R, Schonfelder G, van der Giet M, Henning L, et al. Uridine adenosine tetraphosphate: a novel endothelium-derived vasoconstrictive factor. Nat Med. 2005;11:223\u20137.","journal-title":"Nat Med"},{"key":"2038_CR4","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1161\/ATVBAHA.107.143958","volume":"8","author":"V Jankowski","year":"2007","unstructured":"Jankowski V, Meyer AA, Schlattmann P, Gui Y, Zheng XL, Stamcou I, Radtke K, Tran TN, M.van der Giet, M. Tolle, W. Zidek, J. Jankowski, Increased uridine adenosine tetraphosphate concentrationsin plasma of juvenile hypertensives. Arterioscler Thromb Vasc Biol. 2007;8:1776\u201381.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2038_CR5","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/CIRCRESAHA.108.177865","volume":"103","author":"M T\u00f6lle","year":"2008","unstructured":"T\u00f6lle M, Jankowski V, Schuchardt M, Wiedon A, Huang T, Hub F, et al. Adenosine 5\u2032-tetraphosphate is a highly potent purinergic endothelium-derived vasoconstrictor. Circ Res. 2008;103:1100\u20138.","journal-title":"Circ Res"},{"issue":"2","key":"2038_CR6","doi-asserted-by":"publisher","first-page":"H409","DOI":"10.1152\/ajpheart.00084.2011","volume":"301","author":"T Matsumoto","year":"2011","unstructured":"Matsumoto T, Tostes RC, Webb RC. Uridine adenosine tetraphosphate-induced contraction isincreased in renal but not pulmonary arteries from DOCA-salt hypertensive rats. Am J Physiol Heart CircPhysiol. 2011;301(2):H409\u201317.","journal-title":"Am J Physiol Heart CircPhysiol"},{"key":"2038_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/435132","author":"T Matsumoto","year":"2011","unstructured":"Matsumoto T, Tostes Rita C, Clinton Webb R. The role of uridine adenosine tetraphosphate in the vascular system. Adv Pharmacol Sci. 2011. https:\/\/doi.org\/10.1155\/2011\/435132.","journal-title":"Adv Pharmacol Sci"},{"key":"2038_CR8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/ajh\/hpw163","volume":"3","author":"Z Zhou","year":"2017","unstructured":"Zhou Z, Yadav VR, Sun C, Teng B, Mustafa JS. Impaired aortic contractility to uridine adenosine tetraphosphate in angiotensin II-induced hypertensive mice: receptor desensitizatio. Am JHypertens. 2017;3:304\u201312.","journal-title":"Am JHypertens"},{"issue":"2","key":"2038_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1748-1716.2010.02135.x","volume":"200","author":"PB Hansen","year":"2010","unstructured":"Hansen PB, Hristovska A, Wolff H, Vanhoutte P, Jensen BL, Bie P. Uridine adenosine tetraphosphate affects contractility of mouse aorta and decreases blood pressure in conscious rats and mice. Acta Physiol (Oxf). 2010;200(2):171\u20139.","journal-title":"Acta Physiol (Oxf)"},{"key":"2038_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1749-6632.1990.tb37659.x","volume":"603","author":"G Burnstock","year":"1990","unstructured":"Burnstock G. Dual control of local blood flow by purines. Ann N Y Acad Sci. 1990;603:31\u201344.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"2038_CR11","first-page":"413","volume":"50","author":"V Ralevic","year":"1998","unstructured":"Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 1998;50(3):413\u201392.","journal-title":"Pharmacol Rev"},{"issue":"22","key":"2038_CR12","doi-asserted-by":"publisher","first-page":"11589","DOI":"10.1073\/pnas.94.21.11589","volume":"94","author":"A Cavalli","year":"1997","unstructured":"Cavalli A, Lattion AL, Hummler E, et al. Decreased blood pressure response in mice deficient of the \u03b11B-adrenergic receptor. PNAS. 1997;94(22):11589\u201394.","journal-title":"PNAS"},{"key":"2038_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-021-01128-7","volume":"23","author":"GK Davis","year":"2021","unstructured":"Davis GK, Fehrenbach DJ, Madhur MS. Interleukin 17A: key player in the pathogenesis of hypertension and a potential therapeutic target. Curr Hypertens Rep. 2021;23:1\u20139.","journal-title":"Curr Hypertens Rep"},{"issue":"6","key":"2038_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/biomedicines9060623","volume":"9","author":"CN Hsu","year":"2021","unstructured":"Hsu CN, Tain YL. Animal models for DOHaD research: Focus on hypertension of developmental origins. Biomedicines. 2021;9(6):623.","journal-title":"Biomedicines"},{"issue":"4","key":"2038_CR15","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1161\/HYPERTENSIONAHA.116.06603","volume":"68","author":"JH Dasinger","year":"2016","unstructured":"Dasinger JH, Davis GK, Newsome AD, Alexander BT. Developmental programming of hypertension: physiological mechanisms. Hypertension. 2016;68(4):826\u201331.","journal-title":"Hypertension"},{"issue":"3","key":"2038_CR16","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1476-5381.2010.00914.x","volume":"161","author":"M Tolle","year":"2010","unstructured":"Tolle M, Schuchardt M, Wiedon A, Huang T, Klockel L, Jankowski J, Jankowski V, Zidek W, M.van der Giet. Differential effects of uridine adenosine tetraphosphate on purinoceptors in the rat isolated perfused kidney. Br J Pharmacol. 2010;161(3):530\u201340.","journal-title":"Br J Pharmacol"},{"key":"2038_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00109-008-0306-6","volume":"86","author":"V Jankowski","year":"2008","unstructured":"Jankowski V, Patzak A, Herget-Rosenthal S, Tran TN, Lai EY, Gunthner T, et al. Uridine adenosine tetraphosphate acts as an autocrine hormone affecting glomerular filtration rate. J Mol Med (Berl). 2008;86:333\u201340.","journal-title":"J Mol Med (Berl)"},{"issue":"4\u20136","key":"2038_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.vph.2008.03.003","volume":"48","author":"AE Linder","year":"2008","unstructured":"Linder AE, Tumbri M, Linder FF, Webb RC, Leite R. Uridine adenosine tetraphosphate induces contraction and relaxation in rat aorta. Vascul Pharmacol. 2008;48(4\u20136):202\u20137.","journal-title":"Vascul Pharmacol"},{"issue":"4","key":"2038_CR19","doi-asserted-by":"publisher","first-page":"L733","DOI":"10.1152\/ajplung.00403.2007","volume":"294","author":"MP Gui","year":"2008","unstructured":"Gui MP, Walsh V, Jankowski J, Jankowski XL. Zheng, Up4A stimulates endotheliumindependent contraction of isolated rat pulmonary artery. Am J Physiol Lung Cell Mol Physiol. 2008;294(4):L733\u20138.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2038_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/ijms18112378","volume":"18","author":"T Matsumoto","year":"2017","unstructured":"Matsumoto T, Kobayashi S, Ando M, Iguchi M, Takayanagi K, Kojima M, Taguchi K, Kobayashi T. Alteration of vascular responsiveness to uridine adenosine tetraphosphate in aortas isolatedfrom male diabetic otsuka long-evans tokushima fatty rats: the involvement of prostanoids. Int J Mol Sci. 2017;18:11.","journal-title":"Int J Mol Sci"},{"key":"2038_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11302-017-9563-6","volume":"13","author":"Z Zhou","year":"2017","unstructured":"Zhou Z, Sorop O, de Beer VJ, Heinonen I, Cheng C, Jan Danser AH, Duncker DJ, Merkus D. Altered purinergic signaling in uridine adenosine tetraphosphate-induced coronary relaxation in swine withmetabolic derangement. Purinergic Signal. 2017;13:319\u201329.","journal-title":"Purinergic Signal"},{"key":"2038_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3389\/fphar.2018.00255","volume":"9","author":"Z Zhou","year":"2018","unstructured":"Zhou Z, Lankhuizen IM, van Beusekom HM, Cheng C, Duncker DJ, Merkus D. Uridine adenosine tetraphosphate-induced coronary relaxation is blunted in swine with pressure overload: arole for vasoconstrictor prostanoids. Front Pharmacol. 2018;9:255.","journal-title":"Front Pharmacol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02038-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-024-02038-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02038-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T06:10:45Z","timestamp":1727503845000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-024-02038-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2038"],"URL":"https:\/\/doi.org\/10.1186\/s40001-024-02038-5","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"18 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of the Ethics Committee of Affiliated Hospital of Hebei University. All animals were treated in compliance with the National Research Council\u2019s Guide for the Care and Use of Laboratory Animals (1996).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"471"}}